Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia

Autor: Patel, Kishan K. *, Zeidan, Amer M. *, Shallis, Rory M., Prebet, Thomas, Podoltsev, Nikolai, Huntington, Scott F.
Zdroj: In Blood Advances 23 February 2021 5(4):994-1002
Databáze: ScienceDirect